Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.

 | 
Results 1-10 of 33 (Search time: 0.021 seconds).
Issue DateTitleAuthor(s)
2018Randomized phase II trial of oral vinorelbine (OV) and cisplatin (P) followed by maintenance with single-agent OV versus (vs) gemcitabine (GEM) and P followed by maintenance with single-agent GEM as first-line chemotherapy (CT) in locally advanced (LA) or metastatic non-small-cell lung cancer (NSCLC) patients (pts) with squamous (sq) histological type.GROSSI, Francesco; JASKIEWICZ, Piotr; PICHON, Eric; CZYZEWICZ, Grzegorz; KOWALSKI, Dariusz; CIUFFREDA, Libero; GARCIA-GOMEZ, Ramon; CARUSO, Salvatore; BOSCH-BARRERA, Joaquim; MINH, Christine Ta Thanh; HENRIET, Sebastien; GAUTIER, Stephanie; HERVIEU, Helene; CASTRO, Gilberto
2014Reversal of T3 Thyrotoxicosis By Lenvatinib in Metastatic Follicular Thyroid Carcinoma: Report of 2 CasesHOFF, Ana O.; DANILOVIC, Debora Seguro; CASTRO, Gilberto; PAPADIA, Carla; MARUI, Suemi; CAMARGO, Rosalinda
2017Factors associated with better overall survival (OS) in patients with previously treated, PD-L1-expressing, advanced NSCLC: Multivariate analysis of KEYNOTE-010.HERBST, Roy S.; BAAS, Paul; KIM, Dong-Wan; FELIP, Enriqueta; PEREZ-GRACIA, Jose Luis; HAN, Ji-Youn; MOLINA, Julian R.; KIM, Joo-Hang; DUBOS, Catherine; AHN, Arvis Myung-Ju; MAJEM, Margarita; FIDLER, Mary J.; CASTRO, Gilberto; GARRIDO, Marcelo; ELLISON, Misoo C.; SAMKARI, Ayman; LUBINIECKI, Gregory M.; GARON, Edward B.
2013Should all patients (pts) with advanced biliary cancers receive first-line treatment with cisplatin and gemcitabine (GC)?MIRANDA, Vanessa Costa; DIB-FARIA, Luiza; BRAGHIROLI, Maria Ignez Freitas Melro; SABBAGA, Jorge; SARAGIOTTO, Daniel Fernandes; CASTRO, Gilberto; HOFF, Paulo M.; RIECHELMANN, Rachel
2019Cachexia in head and neck squamous cell carcinoma (HNSCC) patients (pts) after cisplatin-based chemoradiation (CRT): A cross-sectional study.CASTRO, Gilberto; NEVES, Willian das; RIVELLI, Thomas Giollo; SIMAO, Eduardo Furquim; MARTINS, Renata Eiras; KULCSAR, Marco Aurelio Vamondes
2019Synchronous esophageal cancer impact on survival of head and neck squamous cell carcinoma (HNSCC) patients.DIVINO, Paulo Henrique Amor; MATOS, Gustavo Duarte Ramos; LIMA, Karolina; CASTRO, Gilberto; MARTA, Gustavo Nader; TAKEDA, Flavio Roberto; CECCONELLO, Ivan; BRAGHIROLI, Oddone Freitas Melro; MAK, Milena Perez
2019The ideal amount of physical activity to improve quality of life and symptoms in lung cancer patients: A systematic review.CASTRO, Gilberto; CODIMA, Alberto; NEVES, Willian das; BORGES, Ana Paula Souza
2019The CANOPY program: Canakinumab in patients (pts) with non-small cell lung cancer (NSCLC).PAZ-ARES, Luis G.; GARON, Edward B.; ARDIZZONI, Andrea; BARLESI, Fabrice; CHO, Byoung Chul; CASTRO, Gilberto; MARCHI, Pedro De; FELIP, Enriqueta; GOTO, Yasushi; GREYSTOKE, Alastair; LU, Shun; LIM, Darren Wan Teck; PAPADIMITRAKOPOULOU, Vassiliki; RECK, Martin; SOLOMON, Benjamin J.; SPIGEL, David R.; TAN, Daniel Shao-Weng; THOMAS, Michael; YANG, James Chih-Hsin; JOHNSON, Bruce E.
2012Excision repair cross-complementary group 1 (ERCC1) as a prognostic biomarker in patients (pts) with solid tumors: A meta-analysis on detection methodsMAK, Milena Perez; TAKAHASHI, Tiago Kenji; HOFF, Paulo Marcelo; CASTRO, Gilberto; SNITCOVSKY, Igor M. L.
2016Archival vs new tumor samples for assessing PD-L1 expression in the KEYNOTE-010 study of pembrolizumab (pembro) vs docetaxel (doce) for previously treated advanced NSCLCHERBST, Roy S.; BAAS, Paul; PEREZ-GRACIA, Jose Luis; FELIP, Enriqueta; KIM, Dong-Wan; HAN, Ji-Youn; MOLINA, Julian R.; KIM, Joo-Hang; ARVIS, Catherine Dubos; AHN, Myung-Ju; MAJEM, Margarita; FIDLER, Mary J.; SURMONT, Veerle; CASTRO, Gilberto; GARRIDO, Marcelo; Yue Shentu; DOLLED-FILHART, Marisa; IM, Ellie; GARON, Edward B.